Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Systematic Review
Authors: Toh, Keith Z.X.a; 1; * | Koh, Ming Yia; 1 | Loh, Enver D.W.a | Sia, Ching-Huib; c | Chong, Yaofengd | Yeo, Leonard L.L.b; d | Sharma, Vijay K.d | Lim, Mervyn J.R.e | Tan, Benjamin Y.Q.b; d
Affiliations: [a] Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore | [b] Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore | [c] Department of Cardiology, National University Heart Centre, Singapore | [d] Department of Medicine, Division of Neurology, National University Hospital, Singapore | [e] Department of Surgery, Division of Neurosurgery, National University Hospital, Singapore
Correspondence: [*] Correspondence to: Keith Zhi Xian Toh, Lee Kong Chian School of Medicine, Nanyang Technological University, 11 Mandalay Road Singapore 308232, Singapore. E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background:Cognitive impairment, and in the long term Alzheimer’s disease, vascular, or mixed dementia, are potential complications of moyamoya disease (MMD), of which the prevalence and associations are not well established. Objective:We performed a systematic review and meta-analysis to investigate the prevalence of cognitive impairment in adult patients with MMD as well as its clinical and demographic correlates. Methods:We performed a systematic search of four electronic databases: PubMed (MEDLINE), EMBASE, Scopus, and Cochrane Library, profiling studies from inception until 7 May 2023. Clinical data consisting of population characteristics, comorbidities, cognitive assessment tools used, and prevalence of cognitive impairment was extracted. Results:Seventeen studies were included in the meta-analysis, with a total study population of 1,190 patients. All studies assessed cognition, and the overall prevalence of cognitive impairment in MMD patients was 54.59%. A subgroup analysis identified that the prevalence of executive dysfunction in MMD patients was 31.55%. We performed a meta-regression analysis which identified that cognitive impairment was not associated with age, education level, or a history of ischemic or hemorrhagic stroke. Conclusions:A substantial proportion of MMD patients have cognitive impairment, and cognitive impairment was found to have no association with a history of stroke. Further research is necessary to investigate the longitudinal relationship of MMD and cognitive impairment, and the impact of bypass surgery on cognitive impairment.
Keywords: Alzheimer’s disease, cognitive impairment, moyamoya disease, prevalence
DOI: 10.3233/JAD-230979
Journal: Journal of Alzheimer's Disease, vol. 97, no. 2, pp. 541-552, 2024
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]